Search Results

There are 6926 results for: content related to: Phase IV study comparing incobotulinumtoxin A and onabotulinumtoxin A using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines

  1. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 9, October 2011, Pages: 1358–1373, Sheena K. Aurora, Paul Winner, Marshall C. Freeman, Egilius L. Spierings, Jessica O. Heiring, Ronald E. DeGryse, Amanda M. VanDenburgh, Marissa E. Nolan and Catherine C. Turkel

    Version of Record online : 29 AUG 2011, DOI: 10.1111/j.1526-4610.2011.01990.x

  2. You have free access to this content
    OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 6, June 2010, Pages: 921–936, David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener and Mitchell F. Brin

    Version of Record online : 7 MAY 2010, DOI: 10.1111/j.1526-4610.2010.01678.x

  3. Advances in the use of botulinum neurotoxins in facial esthetics

    Journal of Cosmetic Dermatology

    Volume 11, Issue 1, March 2012, Pages: 42–50, Timothy Corcoran Flynn

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1473-2165.2011.00593.x

  4. You have full text access to this OnlineOpen article
    Development of onabotulinumtoxinA for chronic migraine

    Annals of the New York Academy of Sciences

    Volume 1329, Issue 1, November 2014, Pages: 67–80, Scott M. Whitcup, Catherine C. Turkel, Ronald E. DeGryse and Mitchell F. Brin

    Version of Record online : 18 AUG 2014, DOI: 10.1111/nyas.12488

  5. You have free access to this content
    Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 9, October 2010, Pages: 1406–1418, Andrew Blumenfeld, Stephen D. Silberstein, David W. Dodick, Sheena K. Aurora, Catherine C. Turkel and William J. Binder

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1526-4610.2010.01766.x

  6. Long-Term Treatment of Glabellar Rhytides Using OnabotulinumtoxinA

    Dermatologic Surgery

    Volume 37, Issue 7, July 2011, Pages: 918–928, ROGER A. DAILEY, ASHA PHILIP and GREG TARDIE

    Version of Record online : 16 MAY 2011, DOI: 10.1111/j.1524-4725.2011.02024.x

  7. The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: A systematic review and meta-analysis

    Neurourology and Urodynamics

    Volume 34, Issue 5, June 2015, Pages: 413–419, Yuanshan Cui, Xin Zhou, Huantao Zong, Huilei Yan and Yong Zhang

    Version of Record online : 28 MAR 2014, DOI: 10.1002/nau.22598

  8. You have free access to this content
    Botulinum toxin type A for the treatment of lower urinary tract disorders

    International Journal of Urology

    Volume 19, Issue 3, March 2012, Pages: 202–215, Teruhiko Yokoyama, Michael B Chancellor, Keiji Oguma, Yumiko Yamamoto, Tomonori Suzuki, Hiromi Kumon and Atsushi Nagai

    Version of Record online : 6 JAN 2012, DOI: 10.1111/j.1442-2042.2011.02946.x

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  10. OnabotulinumtoxinA: A Meta-Analysis of Duration of Effect in the Treatment of Glabellar Lines

    Dermatologic Surgery

    Volume 38, Issue 11, November 2012, Pages: 1794–1803, Richard Glogau, Michael Kane, Frederick Beddingfield, Christine Somogyi, Xiaofang Lei, Carrie Caulkins and Conor Gallagher

    Version of Record online : 26 OCT 2012, DOI: 10.1111/j.1524-4725.2012.02582.x

  11. Dose response with onabotulinumtoxinA for post-stroke spasticity: A pooled data analysis

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 209–215, Stuart A. Yablon, Mitchell F. Brin, Amanda M. VanDenburgh, Jihao Zhou, Susan M. Garabedian-Ruffalo, Susan Abu-Shakra and Frederick C. Beddingfield III

    Version of Record online : 19 OCT 2010, DOI: 10.1002/mds.23426

  12. Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 10, November/December 2011, Pages: 1573–1577, Paul L. Durham and Roger Cady

    Version of Record online : 14 NOV 2011, DOI: 10.1111/j.1526-4610.2011.02022.x

  13. You have free access to this content
    A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue 10, November/December 2009, Pages: 1466–1478, Ninan T. Mathew and Sayyed Farhan A. Jaffri

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1526-4610.2009.01566.x

  14. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections

    Journal of Cosmetic Dermatology

    Volume 13, Issue 3, September 2014, Pages: 224–231, Neal D Goldman, Leighanne H Dorton, Kristin K Marcum, Ryan M Gilbert and Laura F Sandoval

    Version of Record online : 6 SEP 2014, DOI: 10.1111/jocd.12098

  15. Abstracts

    Neurourology and Urodynamics

    Volume 34, Issue S3, August 2015, Pages: S1–S461,

    Version of Record online : 5 JUL 2015, DOI: 10.1002/nau.22830

  16. Difficult Urination Does Not Affect the Successful Outcome after 100U OnabotulinumtoxinA Intravesical Injection in Patients with Idiopathic Detrusor Overactivity

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 1, January 2012, Pages: 29–34, Yih-Chou CHEN and Hann-Chorng KUO

    Version of Record online : 12 SEP 2011, DOI: 10.1111/j.1757-5672.2011.00102.x

  17. Noninferiority of IncobotulinumtoxinA, Free from Complexing Proteins, Compared with Another Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

    Dermatologic Surgery

    Volume 36, Issue s4, December 2010, Pages: 2146–2154, GERHARD SATTLER, MICHAEL J. CALLANDER, DORIS GRABLOWITZ, TORSTEN WALKER, EVA K. BEE, BERTHOLD RZANY, TIMOTHY CORCORAN FLYNN and ALASTAIR CARRUTHERS

    Version of Record online : 6 DEC 2010, DOI: 10.1111/j.1524-4725.2010.01706.x

  18. Handling Botulinum Toxins: An Updated Literature Review

    Dermatologic Surgery

    Volume 37, Issue 11, November 2011, Pages: 1553–1565, ADA R. TRINDADE DE ALMEIDA, LETICIA CARDOSO SECCO and ALASTAIR CARRUTHERS

    Version of Record online : 21 JUL 2011, DOI: 10.1111/j.1524-4725.2011.02087.x

  19. You have full text access to this OnlineOpen article
    Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine

    European Journal of Neurology

    Volume 21, Issue 6, June 2014, Pages: 851–859, H.-C. Diener, D. W. Dodick, C. C. Turkel, G. Demos, R. E. DeGryse, N. L. Earl and M. F. Brin

    Version of Record online : 15 MAR 2014, DOI: 10.1111/ene.12393

  20. You have full text access to this OnlineOpen article
    Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 10, November/December 2014, Pages: 1565–1573, John F. Rothrock, Lisa M. Bloudek, Timothy T. Houle, Diane Andress-Rothrock and Sepideh F. Varon

    Version of Record online : 8 OCT 2014, DOI: 10.1111/head.12456